Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.

Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. , and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make ...

Inspiratm Technologies OXY B.H.N. Ltd. ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced positive initial results from its previously reported ...